Sakaue, Saori https://orcid.org/0000-0003-3618-9717
Gurajala, Saisriram
Curtis, Michelle https://orcid.org/0000-0002-6843-4839
Luo, Yang https://orcid.org/0000-0001-7385-6166
Choi, Wanson https://orcid.org/0000-0003-1251-8213
Ishigaki, Kazuyoshi https://orcid.org/0000-0003-2881-0657
Kang, Joyce B.
Rumker, Laurie
Deutsch, Aaron J. https://orcid.org/0000-0001-6750-5335
Schönherr, Sebastian
Forer, Lukas
LeFaive, Jonathon https://orcid.org/0000-0003-3668-6086
Fuchsberger, Christian
Han, Buhm
Lenz, Tobias L.
de Bakker, Paul I. W.
Okada, Yukinori https://orcid.org/0000-0002-0311-8472
Smith, Albert V.
Raychaudhuri, Soumya https://orcid.org/0000-0002-1901-8265
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063759)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (UC2AR081023)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (U01HG012009)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Uehara Memorial Foundation
the Manabe Scholarship Grant for Allergic and Rheumatic Diseases the Osamu Hayaishi Memorial Scholarship
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007028)
Deutsche Forschungsgemeinschaft (437857095)
Japan Agency for Medical Research and Development (JP22km0405211)
Japan Agency for Medical Research and Development (JP22km0405217)
Article History
Received: 10 August 2022
Accepted: 27 April 2023
First Online: 26 July 2023
Competing interests
: B.H. is a CTO of Genealogy Inc. T.L.L. is a co-inventor on a patent application for using HLA evolutionary divergence in predicting cancer immunotherapy success. S.R. is a founder for Mestag, Inc, a scientific advisor for Sonoma, Jannsen and Pfizer, and serves as a consultant for Sanofi and Abbvie.